(Total Views: 92)
Posted On: 04/24/2019 9:10:42 AM
Post# of 35809

$LJPC News Article - La Jolla Pharmaceutical Company Announces U.S. FDA's Grant of Breakthrough Therapy Designation for LJPC-0118 for the Treatment of Severe Malaria https://marketwirenews.com/news-releases/la-j...49616.html


My Twitter: WhyteStocks